FQ
SILK

First Quadrant’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

First Quadrant’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,060
Closed -$96K – 855
2020
Q1 		$96K Buy
+3,060
New +$123K 0.01% 469

Other funds holding SILK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

First Quadrant's SILK Position: Q2 2020 in Review

First Quadrant sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2020, closing a stake of 3,060 shares — an estimated $96K sold.

First Quadrant first reported a position in SILK in Q1 2020 and held it in 1 quarter. The position peaked at $96K in Q1 2020. 154 funds tracked by Wall St. Rank hold SILK as of Q2 2020.

  • First Quadrant reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • First Quadrant sold 3,060 Silk Road Medical, Inc. Common Stock shares in Q2 2020, an estimated $96K.
  • First Quadrant first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • First Quadrant's Silk Road Medical, Inc. Common Stock position peaked at $96K in Q1 2020.
  • 154 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2020.

Based on First Quadrant's 13F filing for Q2 2020, filed 28 Jul 2020.